AMYOTROPHIC LATERAL SCLEROSIS (ALS)
Gene Symbol: SOD1
Chromosomal Locus: 21q22.11
Protein: Superoxide dismutase
Pseudonyms: Lou Gehrig Disease
TURNAROUND TIME: 4 weeks
TESTING METHODOLOGY: Polymerase chain reaction (PCR) and DNA Sequencing of all 5 exons, and their intron- exon borders.
- Collect: Prefer two 5ml whole blood EDTA (lavender top) tube.
- Min. Collection: 0.7 ml whole blood EDTA.
- Transport: blood EDTA at Room Temp shipped regular next day air (No Saturday delivery; store specimen at 40°C and ship Monday).
- Stability: Ambient: up to 7 days; Refrigerated: 2 weeks. Frozen: unacceptable
- Unacceptable Conditions: Serum. Frozen or severely hemolyzed blood. Clotted blood.
- Prenatal testing: Direct: 5ml direct unspun amniotic fluid or 15mg CVS tissue with a backup flask growing. Culture: confluent T25 flask. Maternal blood sample is required for maternal cell contamination studies.
A Molecular Genetics Laboratory Test Requisition must accompany the specimen. Contact the Molecular Laboratory at 918-502-1721 to obtain further information.
Counseling and informed consent are recommended for genetic testing; a Consent form
is available as a resource, but not required.
Incidence: approximately 4 to 8 in 100,000. Approximately 10% of all cases are familial (FALS).
Inheritance: Autosomal dominant in the familial form. Sporadic cases may be due to de novo mutations. ALS may also be acquired due to environmental exposures.
Disease Characteristics: Progressive adult-onset neurodegeneration involving both upper and lower motor neurons of the brain and spinal cord. Symptoms include weakness, stumbling, hyperreflexia, muscular atrophy and paralysis. The mean age onset of FALS (familial ALS) is age 46. Death usually results from compromise of the respiratory muscles.
Molecular Genetic Mechanism: A variety of missense, nonsense and insertion/deletion mutations have been described in the gene.
Clinical Sensitivity: 20% of cases of FALS and 3% of sporadic ALS cases will have an identifiable SOD1 mutation.
Analytic Sensitivity: 99%
Test Limitations: Deletions of the entire gene or mutations that are not in the sequenced segments of the SOD1 gene will not be detected.
INDICATIONS FOR USE:
- To determine whether SOD1 is responsible for FALS in a patient.
- SOD1 testing is appropriate in any individual with ALS who has another affected family member or an incomplete family history, including the early death of a close relative.